Last reviewed · How we verify
Pregabalin 50mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Pregabalin 50mg (Pregabalin 50mg) — Hospital for Special Surgery, New York.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pregabalin 50mg TARGET | Pregabalin 50mg | Hospital for Special Surgery, New York | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pregabalin 50mg CI watch — RSS
- Pregabalin 50mg CI watch — Atom
- Pregabalin 50mg CI watch — JSON
- Pregabalin 50mg alone — RSS
Cite this brief
Drug Landscape (2026). Pregabalin 50mg — Competitive Intelligence Brief. https://druglandscape.com/ci/pregabalin-50mg. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing